Depomed reported $2.33M in Interest Expense on Debt for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Aerie Pharmaceuticals AERI:US $ 1.64M 0M
Aurora Cannabis Inc ACB:CN 25.8M 9.89M
Depomed DEPO:US $ 2.33M 0.11M
Ironwood Pharmaceuticals IRWD:US $ 2.21M 0.13M
Knight Therapeutics Inc GUD:CN C$ 1.11M 220K
Nektar Therapeutics NKTR:US $ 7.23M 0.3M
Omeros OMER:US $ 4.94M 10K
Pfizer PFE:US $ 293M 29M
Teva Pharmaceutical TEVA:IT 225M 13M